Westpac Banking Corp
WBC
CommBank
CBA
Fortescue Ltd
FMG
Rio Tinto Ltd
RIO
National Australia Bank Ltd
NAB
AU Stock MarketDetailed Quotes
NUZ Neurizon Therapeutics Ltd
- 0.170
- +0.005+3.03%
20min DelayMarket Closed Dec 27 15:39 AET
83.62MMarket Cap-8.10P/E (Static)
0.175High0.165Low202.97KVolume0.165Open0.165Pre Close34.57KTurnover0.24552wk High0.06%Turnover Ratio491.91MShares0.16052wk Low-0.021EPS TTM58.77MFloat Cap0.245Historical HighLossP/E (Static)345.70MShs Float0.160Historical Low-0.021EPS LYR6.06%Amplitude--Dividend TTM8.10P/B1Lot Size--Div YieldTTM
About Neurizon Therapeutics Ltd Company
Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).
Company Profile
SymbolNUZ
Company NameNeurizon Therapeutics Ltd
Founded2000
MarketASX
Employees52
Fiscal Year Ends06-30
Address96-100 Albert Road Level 4
CityMelbourne
CountryAustralia
Zip Code3205
Phone+61 396927222
Websitehttps://www.neurizon.com
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED
Level 17, 221 St Georges Terrace, PERTH, WA, AUSTRALIA, 6000
1300 850 505
Company Executives
- Name
- Position
- Salary
- Michael Thurn
- Chief Executive Officer,Managing Director
- --
- Sergio Duchini
- Non-Executive Chairman,Non-Executive Director
- --
- Kathryn(Katie) MacFarlane
- Non-Executive Director
- --
- Marcus Hughes
- Non-Executive Director
- --